Schrodinger Inc
SDGR · NASDAQ
Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based software platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrödinger's multidisciplinary drug discovery team also leverages its software platform to advance collaborative programs and its own pipeline of novel therapeutics to address unmet medical needs.
Market Data
Price
$12.63
-0.32 (-2.47%)
Market Cap$956M
P/E Ratio—
EPS$—
52W High$27.63
52W Low$11.11
Beta1.64
Data from Finnhub · Updated Mar 11, 2026